Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-08-27

Clinical Trial Update: The Water-Blueberry Study [Phase 1, Phase 2]

View source ↗

Summary

An update on a Phase 1/Phase 2 clinical trial (Water-Blueberry Study) sponsored by the University of Oslo for cardiovascular disease, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Oslo | Conditions: Cardiovascular Disease | Phase 1, Phase 2 | Status: COMPLETED